Universe Pharmaceuticals INC · Drugmakers

UPC

High riskNext report: Not enough history

View price ↗

The short version

A company still losing money with shrinking sales, with elevated risk.

Going well

Little debt

Watch out for

Losing money, losses are large next to sales
Revenue down 22.4% from the year before
1 offering filing in 6 months (may sell new shares)

Money moves

No insider buying or selling in the last 30 days

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$3.06-30.0% that day

From UPC's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

1/6Weak

MissReturn on equity 15%+Earns a lot on the money owners have in the business.-7.2%
PassDebt under half of equityNot relying on borrowed money.0.04x equity
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-20.6%
MissProfitable every yearSteady profits, not one good year.3 of 7 years
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$5.3B
MissGross margin 40%+Pricing power: sells for well above what it costs to make.35.3%

Revenue: $17.9B; -22.4% vs prior year
Total debt: $2.1B; 0.04x equity
Current ratio: 4.07x; short-term assets / bills due
Free cash flow: -$5.3B; -29.8% of revenue

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: share count not growing. A checklist is a starting point for research, not a verdict.

Insider rating

Last 90 days

No open-market insider buys or sells in the last 90 days.

Weekly insider trend

No trades to chart yet.

Filing buzz

Last 7 days vs normal

0/ 100

This week: 0
Normal week: 1.2
vs normal: 0.0x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Newly held

Institutions held almost none of it the quarter before (new listing, spin-off or ticker change), so there's no fair percent change yet. 4 bought, 0 sold.

Shares held by institutions37K

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

+83.8%

Cash runwayAt last year's cash burn

80 months

Debt to equityLatest balance sheet: debt compared with what owners have

No debt reported

Shares outstandingLatest reported

563K

Why high risk

Losing money, losses are large next to sales
Share count growing 83.8% a year (dilution)
Revenue down 22.4% from the year before
1 offering filing in 6 months (may sell new shares)

Earnings reports

Last 0

Next reportNot enough history

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

Insider trades

Open-market buys and sells, last 90 days

No open-market buys or sells in 90 days. Grants and option exercises are left out.

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Latest filings

Straight from SEC EDGAR

Source: SEC EDGAR filings. For informational purposes. Not investment advice.

Report a problem with this page